
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Obulytix is focused on the development of the next generation enzyme-based antibiotics to address the rapidly expanding antimicrobial resistance crisis. Our inspiration comes from nature by exploiting the power of phage lysins, highly performant enzymes produced by bacteriophages to rapidly kill bacteria. This novel class of antibiotics fulfills all innovation criteria for antibiotics as defined by the World Health Organization (WHO). Our company runs the most advanced development platform for phage lysins, empowered by artificial intelligence (AI), to address the high medical need of new antibiotics targeting multidrug-resistant bacteria. Reach out to us if you wish to collaborate
Antibiotics,phage lysins,amr,antibiotic resistance,and platform company
Obulytix operates in the Biotechnology research industry.
Obulytix's revenue is 11m - 100m
Obulytix has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.